WX

WebserviceX

Agentic AI Equity Research

Coverage blotter·Stock analysis hub·Note 2026-07-20·Latest →

BlackRock (BLK) Stock Analysis

OW

BLK Equity Research — OVERWEIGHT — July 2026

← BKBRK.B →

Rating date

Jul 20, 2026

21 days ago

Desk view

OW

5D move

—

Awaiting market data

Peer rank

85p

Research history

2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 more

Investment card · BLK

The 50-day SMA has been declining since late May 2026 (from ~$1,025 down to a low near $1,016 in late June before edging back up to $1,033). The 200-day SMA has been gradually declining from ~$1,060 in early June to $1,049 — confirming a...

Desk rating

OW

Tactical OW · 12M OW

Horizon

Short to medium term

Confidence

Medium

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

OVERWEIGHT

Catalysts

  • Near-term momentum is bullish: MACD has crossed above zero, RSI has recovered from oversold, and price has reclaimed both the 50- and 200-day SMAs.
  • Medium-term structure remains bearish: The death cross (50-SMA below 200-SMA) is not yet resolved. A sustained close above ~$1,100 would be needed to invalidate it.
  • Volatility has been exceptional: The 15% round-trip from $950 to $1,093 and back toward $1,070 in three weeks is well above BLK's typical range.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

BLK Research Note

Full desk note for Jul 20, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

24 min read

WebserviceX · Agentic Research Desk

BLK Equity Research Note

Published Jul 20, 2026 · Desk view OVERWEIGHT · Generated 2026-07-21T15:34:09Z · Maintained by Walter Vijayakumar · Methodology · Track record

BLK Stock Rating Summary

BLK bias

OVERWEIGHT

Horizon

Short to medium term

BLK key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

BLK catalyst watch

Near-term momentum is bullish: MACD has crossed above zero, RSI has recovered from oversold, and price has reclaimed both the 50- and 200-day SMAs.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Medium

How the call aged · 5D

—Awaiting market dataPeer 85p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-07-21T15:52:18.239265+00:00.

5D move

—

2026-07-20 → awaiting

Outcome

Awaiting market data

5D trend

+2.19%

Vol (20D ann.)

+35.67%

vs SPY: +3.13%

Close 1054.11 → — (USD, vendor closes)

Batch scorecard · 2026-07-20 · BLK

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace 26d0afd4…

No QC issues recorded.